NDC 44567-501-01 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 44567-501
- Requested NDC
- 44567-501-01
- Package NDCs from labels
- 44567-501-01, 44567-501-10, 44567-501-02, 44567-501-90
- Manufacturer
- WG Critical Care, LLC
- Effective date
- 2024-03-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - WG Critical Care, LLC | WG Critical Care, LLC | 2024-03-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Levetiracetam - WG Critical Care, LLC | WG Critical Care, LLC | 2023-10-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44567-501-01 | Levetiracetam | 100 mL in 1 BAG | INJECTION | 100 | 6 | |
| 44567-501-10 | Levetiracetam | 10 in 1 CARTON | INJECTION | 10 | 6 | |
| 44567-501-02 | Levetiracetam | 100 mL in 1 BAG | INJECTION | 100 | 3 | |
| 44567-501-90 | Levetiracetam | 10 in 1 CARTON | INJECTION | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 44567-501 | LEVETIRACETAM INJECTION [WG CRITICAL CARE, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20240601_62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926.zip |
| 44567-501 | LEVETIRACETAM INJECTION [WG CRITICAL CARE, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20240113_5e5b0ed3-b104-45a7-bb3e-ee56febb46e8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44567-501-01 | ML - Milliliter | 44567-501 | 9e2d0692-78d1-449a-9b18-1555c0c12a1b | 1 | 2022-07-06 |
| 44567-501-02 | ML - Milliliter | 44567-501 | 99ebf4bb-00a7-4827-b7a9-becb303cd0f8 | 1 | 2023-06-06 |
| 44567-501-10 | ML - Milliliter | 44567-501 | cff2ee94-7849-4182-85fb-4dd98195753d | 1 | 2022-06-06 |
| 44567-501-90 | ML - Milliliter | 44567-501 | 080c3ef7-7acd-460a-a666-737f289d63c7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glyreg | ACETICUM ACIDUM, CACAO, MAGNESIA SULPHURICA, NATRUM SULPHURICUM, VERBASCUM THAPSUS, GLANDULA SUPRARENALIS SUIS, PANCREAS SUIS, CORTISONE ACETICUM, THYROIDINUM (SUIS), IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORUS, RANUNCULUS BULBOSUS, SACCHARUM OFFICINALE, VANADIUM METALLICUM, ZINCUM METALLICUM, CHROMIUM ACIDUM, CULEX MUSCA | Deseret Biologicals, Inc | 28e670ca-ed35-4256-af20-74c25dc18099 | 2024-04-23 | Warnings | Q40Q9N063P |
| PEMF Optimizer | AQUA SULIS, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, LAPIS ALBUS, MANGANUM METALLICUM VANADIUM METALLICUM VISCUM ALBUM, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 97d57469-4c5b-4d3f-9398-3a1a6617a649 | 2024-04-23 | Warnings | 059QF0KO0R |
| Dermapar | EPIDERMIS (SUIS), ARSENICUM ALBUM, CALCAREA CARBONICA, GRAPHITES, MEZEREUM, NATRUM MURIATICUM, NITRICUM ACIDUM, PETROLEUM, RHUS TOX, SULPHUR, CAUSTICUM | Energique, Inc. | f79fe29b-341e-4bee-9665-1805a7157d1a | 2024-04-22 | Warnings | 451W47IQ8X |
| levetiracetam | LEVETIRACETAM | Sagent Pharmaceuticals | d2de9565-0c0b-4957-bafa-1a286103709e | 2024-04-18 | Warnings, Adverse reactions | 1193358 1193362 1193360 44YRR34555 |
| Levetiracetam in Sodium Chloride | LEVETIRACETAM IN SODIUM CHLORIDE | Hikma Pharmaceuticals USA Inc. | c723fd27-214c-45f6-b170-a3b807ffab07 | 2024-04-12 | Warnings, Adverse reactions | 1193358 1193362 1193360 44YRR34555 |
| Sterile Water | WATER | Hikma Pharmaceuticals USA Inc. | 78ef7ad3-451d-43d0-a9b6-5cf0aadca003 | 2024-04-10 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Hikma Pharmaceuticals USA Inc. | e5ee8caa-b6ca-45ba-98fb-8305e6282141 | 2024-04-10 | Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | B. Braun Medical Inc. | 8fc8d87a-3951-4ac5-97df-c161ffc90475 | 2024-04-10 | Warnings, Adverse reactions | 059QF0KO0R |
| Hers Plus | CALENDULA OFFICINALIS, SAMBUCUS NIGRA, ALLIUM SATIVUM, CLEMATIS ERECTA, DULCAMARA, SARSAPARILLA (SMILAX REGELII), GRAPHITES, PETROLEUM, ARSENICUM ALBUM, CROTON TIGLIUM, MERCURIUS SULPHURATUS RUBER, NATRUM MURIATICUM, NITRICUM ACIDUM, RHUS TOX, SEPIA, THUJA OCCIDENTALIS | Deseret Biologicals,Inc. | e4636b80-f6c8-459c-8d0e-ff7801358b10 | 2024-04-09 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | Aurobindo Pharma Limited | 2471ee03-d747-4113-86d0-1aa93c8f3eba | 2024-04-04 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Novadoz Pharmaceuticals LLC | 484e8d8f-be40-46f8-a509-d1bbdbbd2981 | 2024-04-04 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | ed8e88d0-993e-4683-bdcf-31578130d3df | 2024-04-03 | Warnings, Adverse reactions | 44YRR34555 |
| SINU HC | PLANTAGO MAJOR, PULSATILLA (PRATENSIS), LUFFA OPERCULATA, MERCURIUS IODATUS RUBER, MUCOSA NASALIS SUIS, EUPHORBIUM OFFICINARUM, ARGENTUM NITRICUM, HEPAR SULPHURIS CALCAREUM, CALCAREA CARBONICA, NATRUM MURIATICUM, SINUSITISINUM | Deseret Biologicals, Inc. | 8b63e066-dd1b-4aee-a17b-4edc6b71a1cc | 2024-04-02 | Warnings | 451W47IQ8X |
| Eye Wash | WATER | M-star (Hubei) Health&Care Products Co., Ltd. | 71706039-e250-4f08-9687-71b2928c4e46 | 2024-04-01 | Warnings | 059QF0KO0R |
| Levetiracetam | LEVETIRACETAM IN SODIUM CHLORIDE | Eugia US LLC | e5eb4c89-8ee9-4474-9cb1-c3b3dc262a4a | 2024-04-01 | Warnings, Adverse reactions | 1193358 1193362 1193360 44YRR34555 |
| 5d75a4ee-4a82-48d9-809b-eabea28c6e96 | 62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926 | 2024-03-29 | Warnings, Adverse reactions | 5d75a4ee-4a82-48d9-809b-eabea28c6e96 62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926 | ||
| LEVETIRACETAM | LEVETIRACETAM | Solco healthcare U.S., LLC | bc8644ed-3320-47b5-adf3-8b972bea8abd | 2024-03-28 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Solco Healthcare US, LLC | 57f09129-7151-4a75-9d73-9dd32f74ba43 | 2024-03-27 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Solco Healthcare US, LLC | dd713e60-478c-43cd-b680-ff594a0b3864 | 2024-03-27 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | PAI Holdings, LLC dba PAI Pharma | 9dca1330-52ca-47a4-a134-ec55c9d5786d | 2024-03-27 | Warnings, Adverse reactions | 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.